Interparfums

Interparfums
Headquarters in Paris, France
Trade name	Interparfums
Type	Société anonyme
Traded as	Euronext Paris: ITP SBF 120 component
ISIN	FR0004024222
Industry	Perfume
Founded	1982; 44 years ago (1982)
Founders	Philippe Bénacin Jean Madar
Headquarters	10 rue de Solférino Paris, France
Area served	Worldwide
Key people	Philippe Bénacin, Jean Madar
Products	Perfumes
Services	Department stores
Website	www.interparfums.fr

Interparfums is a French company listed on Euronext Paris, which manufactures and distributes prestige perfumes.

History

The company was founded in 1982 by Philippe Bénacin and Jean Madar. It initially focused on the mass-market perfumery, designing and distributing affordable eau de toilette , before shifting its focus to the niche of selective perfumery in the early 1990s.

In 1993, the signing of a perfume licensing agreement with the British brand Burberry marked the first step in a strategy aimed at building a portfolio of international brands, including Karl Lagerfeld, ready-to-wear brands (Lanvin), fine jewelry (Van Cleef & Arpels, Boucheron), and accessories (S. T. Dupont, Montblanc, Jimmy Choo, and Repetto for Fall 2013), all within the world of perfumes and cosmetics.

Since April 2013, following discussions between the British company and Interparfums, the Burberry brand, which represented half of Interparfums' revenue, has been transferred to BPI (Beauté Prestige International), a subsidiary of Shiseido.

In March 2015, Interparfums acquired Rochas, a Procter & Gamble subsidiary specializing in perfumes and fashion, for $108 million.

In April 2015, Interparfums signed a licensing agreement with the Coach brand.

In 2016, following the acquisition of Balmain by the investment firm Mayhoola, Interparfums decided to terminate the licensing agreement.

On June 7, 2019, Kate Spade New York and Interparfums announced that they had signed an exclusive worldwide licensing agreement for Kate Spade perfumes for a period of 11 years.

On June 11, 2020, Moncler and Interparfums announced the signing of a perfume licensing agreement, valid until December 31, 2026, with a possible five-year extension.

On July 1, 2020, Interparfums acquired 25% of the website "origines-parfums.fr," which will become MyOrigines to accelerate its international development.

In January 2021, the Interparfums Group, formerly located at 4 Rond-point des Champs-Élysées-Marcel-Dassault in the 8th arrondissement of Paris, purchased the building at 10 rue de Solférino (Paris), the former historic headquarters of the Socialist Party in the 7th arrondissement of Paris, from APSYS and established its headquarters there.

For the full year 2021, Interparfums announced a net profit 40% higher than in 2019, the last year before the pandemic, reaching €71.1 million. The following year, the Richemont Group, which licenses several brands to Interparfums, announced its intention to acquire the beauty business, causing a drop in the manufacturer's share price.

In December 2022, Interparfums announced a 15-year global licensing agreement with the Lacoste brand, which will take effect on January 1, 2024.

The company's revenue is expected to increase in 2023 and 2024, reaching €880 million by the end of 2024.

In 2025, Interparfums acquires all intellectual property rights related to Maison Goutal from Amore Pacific. The same year the group launched the brand « Solférino Paris », its first high-end perfumery brand.

Legal case

In 2014, the company Interparfums SA (Paris) was sued by a former employee, Frédéric Desnard. He filed a complaint after experiencing suicidal thoughts, which he attributed to being "sidelined"—a phenomenon known as "bore-out," or forced professional inactivity imposed by an employer.

Following a years-long legal battle, the French subsidiary Interparfums SA was found guilty of moral harassment by the Paris Court of Appeal on June 2, 2020. The court recognized that the forced inactivity the employee endured at work had led to serious health complications. This marked the first conviction in France for this specific type of moral harassment, which, in this particular case, triggered a physical illness (treatment-resistant epileptic seizures).

References

External links

• Official website